18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with131I

被引：2
|
作者：
Rosario, Pedro Weslley [1 ]
机构：
[1] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Rua Domingos Vieira 590, BR-30150240 Belo Horizonte, MG, Brazil
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 13期
关键词：
GUIDELINES;
D O I：
10.1007/s00259-020-05039-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
8
引用
收藏
页码：2950 / 2951
页数：2
相关论文
共 50 条
  • [41] Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin
    Liu, Min
    Cheng, Lingxiao
    Jin, Yuchen
    Ruan, Maomei
    Sheng, Shiwei
    Chen, Libo
    SCIENTIFIC REPORTS, 2018, 8
  • [42] Management impact of FDG PET/CT in patients with differentiated thyroid carcinoma: A comparative study with I-131 whole body scan and serum thyroglobulin
    Boktor, Raef
    Lee, Sze Ting
    Beriangieri, Saivatore
    Scott, Andrew
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [43] MANAGEMENT IMPACT OF FDG PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA: A COMPARATIVE STUDY WITH I-131 WHOLE BODY SCAN AND SERUM THYROGLOBULIN
    Boktor, R.
    Lee, S. T.
    Berlangieri, S. U.
    Scott, A. M.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 23 - 23
  • [44] Thyroglobulin doubling time independently predicts 2-[18F]-FDG-PET/CT results in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan
    Albano, D.
    Cerudelli, E.
    Gazzilli, M.
    Dondi, F.
    Mazzoletti, A.
    Bellini, P.
    Camoni, L.
    Bertagna, F.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S428 - S429
  • [45] Correlation of 18F-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative 131I Whole-Body Scan Results
    Ozkan, Elgin
    Aras, Gulseren
    Kucuk, N. Ozlem
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (05) : 326 - 331
  • [46] Prospective evaluation of 68Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative 131I-whole body scan: comparison with 18F-FDG PET-CT
    Parveen Kundu
    Sneh Lata
    Punit Sharma
    Harmandeep Singh
    Arun Malhotra
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1354 - 1362
  • [47] The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level
    Sertac Asa
    Sabire Yılmaz Aksoy
    Betül Vatankulu
    Anar Aliyev
    Lebriz Uslu
    Meftune Ozhan
    Sait Sager
    Metin Halac
    Kerim Sonmezoglu
    Annals of Nuclear Medicine, 2014, 28 : 970 - 979
  • [48] Prospective evaluation of 68Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative 131I-whole body scan: comparison with 18F-FDG PET-CT
    Kundu, Parveen
    Lata, Sneh
    Sharma, Punit
    Singh, Harmandeep
    Malhotra, Arun
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1354 - 1362
  • [49] The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level
    Asa, Sertac
    Aksoy, Sabire Yilmaz
    Vatankulu, Betul
    Aliyev, Anar
    Uslu, Lebriz
    Ozhan, Meftune
    Sager, Sait
    Halac, Metin
    Sonmezoglu, Kerim
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (10) : 970 - 979
  • [50] (18)FDG WHOLE-BODY PET IN DIFFERENTIATED THYROID-CARCINOMA - FLIPFLOP IN UPTAKE PATTERNS OF (18)FDG AND I-131
    FEINE, U
    LIETZENMAYER, R
    HANKE, JP
    WOHRLE, H
    MULLERSCHAUENBURG, W
    NUKLEARMEDIZIN, 1995, 34 (04) : 127 - 134
12345